SparingVision
0 sources
SparingVision
Summary
SparingVision is an organization[1].
Key Facts
- SparingVision's field of work was Adeno associated virus and gene therapy of the human retina[2].
- SparingVision is in the country of France[3].
- SparingVision is in the country of FR[4].
- SparingVision's instance of is recorded as organization[5].
- SparingVision's headquarters location is recorded as Paris[6].
- SparingVision's industry is recorded as research and development in other physical and natural sciences[7].
- 2016 marks the founding of SparingVision[8].
- 2016-06-22 marks the founding of SparingVision[9].
- SparingVision's official website is recorded as https://sparingvision.com[10].
- SparingVision's official name is recorded as SPARINGVISION[11].
- SparingVision's legal form is recorded as société par actions simplifiée[12].
- SparingVision's legal form is recorded as 6CHY[13].
- SparingVision's funder is recorded as Bpifrance[14].
- SparingVision's funder is recorded as European Innovation Council[15].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 969500V4TM7NAYAGXV60[16]
-
Registered legal name: Sparingvision[17]
-
Legal jurisdiction: FR[18]
-
GLEIF entity category: GENERAL[19]
-
Legal form (ISO 20275 ELF): 6CHY[20]
-
Entity status: ACTIVE[21]
-
LEI registration status: LAPSED[22]
-
Entity created: 2016-06-22[23]
-
LEI first registered: 2019-08-29[24]
-
LEI last updated: 2024-07-13[25]
-
LEI next renewal: 2024-07-13[26]
-
Managing LOU: 969500Q2MA9VBQ8BG884[27]
-
Registration authority: RA000189[28]
-
Authority entity ID: 821148327[29]
-
Conformity flag: NON_CONFORMING[30]
Body
Founding
Recorded inception include 2016[8] and 2016-06-22[9].
Identity
SparingVision's official name is recorded as SPARINGVISION[11].
Operations
SparingVision's headquarters location is recorded as Paris[6].
Industry
SparingVision's industry is recorded as research and development in other physical and natural sciences[7]. SparingVision's field of work was Adeno associated virus and gene therapy of the human retina[2].